Journey Medical Corp Deferred Tax Assets, Operating Loss Carryforwards
Journey Medical Corp (DERM) had Deferred Tax Assets, Operating Loss Carryforwards of $8.04 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.04M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.81M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.38M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.55M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $8.04M 10-K · filed 2026-03-26 |
| 2024-12-31 | $6.81M 10-K · filed 2026-03-26 |
| 2023-12-31 | $4.38M 10-K · filed 2025-03-27 |
| 2022-12-31 | $6.55M 10-K · filed 2024-03-29 |
| 2021-12-31 | $3.11M 10-K · filed 2023-03-31 |
| 2020-12-31 | $5.00K 10-K · filed 2022-03-28 |